News Breaks |
|
|
| March 5, 2013 |
| 11:21 EDT |  | NYMX | Nymox provides update on Phase 2 prostate cancer clinical trial
Nymox provided an update on U.S. Phase 2 prostate cancer clinical trial activities for NX-1207, the company's new investigational drug being tested for early stage prostate cancer. The prostate cancer trial has reached the halfway point in patient recruitment. Safety assessments to date have been positive with no serious or unexpected adverse effects related to the drug. |
|
|
News For NYMX From The Last 14 Days Check below for free stories on NYMX the last two weeks. |
|
|
| There are no results for NYMX |
|
|
|
|
